Eli Lilly and Co on Thursday said its obesity drug achieved a goal of helping patients lose more than 20% of their weight in a late-stage clinical trial.
Eli Lilly and Co on Thursday said its obesity drug achieved a goal of helping patients lose more than 20% of their weight in a late-stage clinical trial.